This site is intended for healthcare professionals only
LoginRegister
NPPA Panel Rejects Dr Reddys Omez ODT Plea For Seperate Price, Finds No Therapeutic EdgeNPPA Panel Rejects Dr Reddy's Omez ODT Plea For Seperate Price, Finds No Therapeutic Edge
CDSCO Panel Approves Phase IV Protocol Amendment for Bristol-Myers Squibbs Mavacamten StudyCDSCO Panel Approves Phase IV Protocol Amendment for Bristol-Myers Squibb's Mavacamten Study
Natco Pharma gets USFDA EIR for Kothur Pharma divisionNatco Pharma Mekaguda API unit gets USFDA EIR
Zydus Told to Rework Phase IV Letermovir StudyZydus Lifesciences receives tentative approval from USFDA for Chronic lymphocytic leukaemia drug...
Roche Itovebi gets European Commission nodRoche Itovebi gets European Commission nod in fight against advanced breast cancer
GSK Gepotidacin approved in UK for UTIs in females aged 12 years and olderUSFDA extends review period for GSK Blenrep in relapsed/refractory multiple myeloma
JnJ gets positive CHMP opinion of nipocalimab for antibody-positive patients living with generalised myasthenia gravisJnJ Darzalex gets European Commission nod for high-risk smouldering multiple myeloma
Lupin wins USFDA nods for Liraglutide, Glucagon Injectable ProductsLupin wins USFDA nods for Liraglutide, Glucagon Injectable Products
Indoco Remedies gets USFDA nod for venous thromboembolism drug RivaroxabanIndoco Remedies gets Certificate of EU GMP Compliance for Goa sterile drug product manufacturing...
Eris Lifesciences Secures CDSCO Panel Nod to Conduct BE Study on Dapagliflozin, Pioglitazone, Metformin FDCEris Gets CDSCO Panel Nod To Dapagliflozin-Bisoprolol-Sacubitril Valsartan Combo Kit, Phase IV Trial...
48 projects approved to avoid disruption in critical APIs supply48 projects approved to ensure uninterrupted supply of critical APIs
Cipla Bommasandra facility gets VAI classification from USFDACDSCO Panel Clears Cipla's Glycopyrronium-Formoterol Inhaler for Phase IV Trial
X